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Introduction {#sec1}
============

In most mammalian species, the postnatal subgranular zone (SGZ) of the hippocampal dentate gyrus (DG) maintains a population of neural precursor cells (NPCs) retaining the lifelong capability to generate new neurons and astrocytes. However, this process inexorably declines with age ([@bib23], [@bib57], [@bib58] and; [@bib38], [@bib16], [@bib46], [@bib36]), and this decline has been correlated with the loss of cognitive abilities and the occurrence of several brain pathologies ([@bib5], [@bib61]). Currently, many translational concepts for preserving cognitive abilities in the aging brain thus aim at sustaining, or even increasing, the potential for cognitive plasticity and flexibility that is contributed by the adult-generated neurons.

Environmental enrichment and physical activity (e.g., voluntary running in a wheel) potentiate adult neurogenesis in rodents ([@bib24], [@bib25], [@bib39], [@bib40], [@bib41], [@bib48], [@bib64]). The positive response of adult neurogenesis to these stimuli is maintained into old age and counteracts the age-associated cognitive decline in rodents and likely in humans ([@bib37], [@bib34], [@bib36], [@bib39], [@bib63]). However, the cellular and molecular mechanisms underlying homeostasis of adult neurogenesis and its response to environmental stimuli remain elusive ([@bib22], [@bib47]). We hypothesize that exploiting these mechanisms is relevant for preventing age-related cognitive decline in humans and that our animal models can contribute to providing evidence-based recommendations for an active lifestyle for successful aging.

The molecular control of adult neurogenesis is highly polygenic ([@bib35]) and very likely regulated at multiple levels, including epigenetic, post-transcriptional as well as post-translational ([@bib22], [@bib60]). Single-cell RNA sequencing efforts start to reveal molecular cascades underlying adult neurogenesis ([@bib56]). However, it remains unclear how the subtle changes in transcript abundance can be translated to biologically relevant protein levels. This enormous complexity thus hinders the identification of the proteins and pathways that are at the top of the molecular control of adult neurogenesis and its response to the environment.

MicroRNAs (miRNAs) are small noncoding RNAs which, by post-transcriptional repression of hundreds of target messenger RNAs (mRNAs) in parallel, tune the entire cell proteome ([@bib55]). The functional synergism of few miRNAs achieves gene regulation essential for proliferation, cell fate determination, and survival in embryonic ([@bib4]) and adult NPCs ([@bib22], [@bib51], [@bib59]). Interestingly, running stimulates hippocampal NPC proliferation ([@bib47]) and alters miRNA expression in rodents ([@bib3], [@bib13], [@bib27], [@bib49]). Hence, we hypothesize that investigating miRNAs involved in running-induced neurogenesis would allow the identification of the most prominent pathways that constrain NPC proliferative potential in the adult mouse hippocampus. With this approach, we aim to uncover the proteins and pathways acting within this circuit-level context, hence providing a system-level biological understanding of scientific and therapeutic value.

Results {#sec2}
=======

Running-Induced Proliferation Downregulates miRNA Expression in Nestin^+^ Adult Hippocampal NPCs *In Vivo* {#sec2.1}
----------------------------------------------------------------------------------------------------------

To investigate whether running alters miRNAs expression in adult hippocampal NPCs, 6-week-old mice, expressing the fluorescent protein CFPnuc under control of the *Nestin* promoter (*Nestin*-CFPnuc), were housed under standard conditions or equipped with a running wheel for 10 days ([Figure 1](#fig1){ref-type="fig"}A). As expected, in the hippocampal SGZ of running mice, we found a statistically significant increase in the number of bromodeoxyuridine (BrdU)-positive cells ([Figure 1](#fig1){ref-type="fig"}B; p = 0.005) and BrdU/*Nestin*-CFPnuc double-positive NPCs ([Figure 1](#fig1){ref-type="fig"}D; p = 0.007), and a slight increase (not statistically significant) in the total number of *Nestin*-CFPnuc-positive NPCs ([Figure 1](#fig1){ref-type="fig"}C; p = 0.136), suggesting an expansion of the proliferative NPC pool.Figure 1Running-Induced Proliferation Downregulates miRNA Expression in Nestin-Positive Adult Hippocampal NPCs *In Vivo*(A) Schematic representation of the experiment.(B--D) (B) Total number of BrdU and (C) *Nestin*-CFPnuc positive adult neural progenitor cells (NPCs), or (D) proportion of BrdU/*Nestin*-CFPnuc double-positive cells counted from the hippocampal SGZ of *Nestin*-CFPnuc mice under standard (STD) or running (RUN) conditions for 10 days; n = 8 mice per group.(E) Quantification of relative expression levels of miR-135-5p, miR-190-5p, and miR-203-3p by TaqMan low density array (TLDA) in sorted *Nestin*-CFPnuc NPCs from the hippocampus of adult mice in STD or RUN conditions.(F) Representative micrographs showing expression of miR-9-5p (positive control), miR-135-5p, miR-190-5p, and miR-203-3p by *in situ* hybridization in the DG and cortex (CTX) of 6-week-old C57Bl6J mice. H, hilus, GCL, granular cell layer; SGZ, subgranular zone.Data are expressed as means ± SEM, n = 3 independent experiments. One-way ANOVA Bonferroni as *post hoc*: ^∗∗^p \< 0.01. Scale bar, 100 μm (large panel), 50 μm (small panel).

We sorted *Nestin*-CFPnuc^+^ NPCs from the DG of resting and running mice and found eight miRNAs that were reproducibly downregulated in runners compared with resting mice ([Figure S1](#mmc1){ref-type="supplementary-material"}, TaqMan low density array \[TLDA\], n = 3 independent biological replicates each containing a pool of *Nestin*-CFPnuc^+^ cells isolated from eight mice per condition). Of relevance, none of the miRNAs in the TLDA were reproducibly induced in *Nestin*-CFPnuc^+^ NPC upon running ([Table S1](#mmc2){ref-type="supplementary-material"}). The three most downregulated miRNAs in *Nestin*-CFPnuc^+^ NPCs from the DG of running mice were mmu-miR-135a-5p (miR-135a), mmu-miR-190-5p (miR-190), and mmu-miR-203-3p (miR-203) ([Figure 1](#fig1){ref-type="fig"}E). By *in situ* hybridization, we found that expression of these miRNAs was enriched in the DG of adult resting mice ([Figure 1](#fig1){ref-type="fig"}F) and that only miR-135a and miR-190 were preferentially enriched in the hippocampal SGZ, where NPCs are located *in vivo* ([Figure 1](#fig1){ref-type="fig"}F). These results indicate that running decreases miRNA expression in hippocampal NPCs *in vivo*, opening the possibility that some of these miRNAs might be involved in the mechanism underlying running-induced proliferation of adult NPCs.

miR-135a Inhibits Cell-Cycle Progression of Cultured Adult NPCs and Mediates Running-Induced Proliferation in the Hippocampal SGZ *In Vivo* {#sec2.2}
-------------------------------------------------------------------------------------------------------------------------------------------

To investigate this possibility, we compared expression of the three miRNAs in cultures of primary hippocampal NPCs ([@bib2]) in quiescence and proliferative conditions. Quiescence is operationally defined here as "non-proliferative" and induced *in vitro* by the addition of bone morphogenetic protein 4 (BMP4, [@bib45]) to the culture medium containing fibroblast growth factor 2 (FGF2/bFGF). Proliferation medium was supplemented with both FGF2 and epidermal growth factor (EGF) ([@bib51], [Figures 2](#fig2){ref-type="fig"}A--2C). As expected, the proportion of BrdU-positive NPCs in proliferative medium was higher than in quiescence medium ([Figures 2](#fig2){ref-type="fig"}A and 2B; p \< 0.001) and, consistent with miRNA profiling of running mice ([Figure 1](#fig1){ref-type="fig"}), proliferating NPCs had significantly lower levels of miR-135a, miR-190, and miR-203 compared with cells in quiescence ([Figure 2](#fig2){ref-type="fig"}C; p \< 0.001).Figure 2miR-135a Levels in Adult NPCs Are Cell-Cycle Dependent and Its Modulation Affects Cell Proliferation *In Vitro*(A and B) Representative micrographs showing (A) BrdU-positive and (B) quantification in primary hippocampal adult NPCs cultured in proliferative medium (EGF + bFGF), or quiescence medium (BMP4 + bFGF).(C) Relative miRNA fold change expression.(D and E) Representative micrographs showing (D) Ki67-positive NPCs and (E) quantification cultured in proliferative medium (EGF + bFGF) upon transfection with 50 nM scrambled control, miR-203-3p, miR-190-5p, miR-135a-5p mimics, or upon transduction with lentivirus transcribing a sponge for miR-135a (sponge miR-135a, i.e., loss of function) or virus expressing control (scrambled) RNAs.Data are expressed as means ± SEM, n = 3 independent experiments containing three replicates. One-way ANOVA Bonferroni as *post hoc*. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. Scale bars, 50 μm.

To ascertain whether miR-135a, miR-190, or miR-203 affects adult NPC proliferation, we transfected synthetic miRNA mimics or scrambled control into NPCs *in vitro* and quantified the proliferative marker Ki67 ([@bib9]). Overexpression of miR-135a, but not miR-203 or miR-190, was sufficient to reduce the proliferation of NPCs ([Figures 2](#fig2){ref-type="fig"}D and 2E; p \< 0.001). Conversely, inhibition of miR-135a, upon transduction with a virus expressing a sponge (loss of function, see also [Figure 3](#fig3){ref-type="fig"}A), led to a significant increase in NPC proliferation ([Figures 2](#fig2){ref-type="fig"}D and 2E). These results indicate an anti-proliferative function of miR-135a in adult hippocampal NPCs *in vitro*.Figure 3Validation of Lentiviruses to Overexpress/Downregulate miR-135a in NPCs *In Vitro* and *In Vivo*(A) Relative expression levels of mature miR-135a in primary NPCs transduced *in vitro* with lentivirus transcribing the immature short-hairpin precursor of miR-135a (sh-miR-135a, i.e., gain of function), or a sponge for miR-135a (sponge miR-135a, i.e., loss of function), or control viruses expressing scrambled RNAs.(B) Representative micrographs showing immunostaining for Nestin-CFPnuc (green), BrdU-positive cells (red), and GFAP-positive cells (white), and nuclear DNA with DAPI (blue) in the hippocampal SGZ of 6- to 8-week-old *Nestin*-CFPnuc mice, injected with lentiviruses (same used in A), kept 10 days under standard conditions and subjected to three injections of BrdU 24 h before sacrifice.(C) Representative micrographs showing immunostaining for Nestin-CFPnuc (green), BrdU-positive cells (red) and nuclear DNA with DAPI (blue) in the hippocampal SGZ of 6- to 8-week-old *Nestin*-CFPnuc mice, injected with miR-135a sponge or scrambled-sponge lentivirus, kept 10 days under standard conditions, and subjected to three injections of BrdU 24 h before sacrifice.(D) Percentage of BrdU and Nestin-CFPnuc double-positive cells over total BrdU^+^ cells in the SGZ of mice injected with lentiviruses.Data are expressed as means ± SEM, n = 7 mice per group. One-way ANOVA Bonferroni as *post hoc*. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. Scale bars, 50 μm (B) and 25 μm (C).

To confirm this result *in vivo*, we transduced lentiviruses expressing either a short-hairpin precursor of miR-135a (sh-miR-135, gain of function), or a sponge for miR-135a, or scrambled control RNA sequences in NPC cultures ([Figure 3](#fig3){ref-type="fig"}A). Expression of miR-135a in NPCs was higher upon transduction with sh-miR-135a and significantly reduced upon transduction with sponge for miR-135a compared with controls ([Figure 3](#fig3){ref-type="fig"}A). We injected the miR-135a sponge or a scrambled control lentivirus in the DG of 6- to 8-week-old *Nestin*-CFPnuc mice housed under standard (resting) conditions. Ten days after injection, we found a higher percentage of *Nestin*-CFPnuc^+^ NPCs upon miR-135 inhibition compared with mice injected with the scrambled control using flow cytometry (sponge 1.6%, [Figure S2](#mmc1){ref-type="supplementary-material"}B; control 1.2%, [Figure S2](#mmc1){ref-type="supplementary-material"}A). In another set of experiments ([Figures 3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, and [5](#fig5){ref-type="fig"}), we administered BrdU (three injections every 2 h) 10 days after virus injection and killed the mice 24 h after the first BrdU administration. We found in both control and miR-135a sponge-injected mice that \>90% of the BrdU-positive cells also expressed Nestin-CFPnuc ([Figures 3](#fig3){ref-type="fig"}B--3D) and glial fibrillary acidic protein (GFAP) ([Figure 3](#fig3){ref-type="fig"}B), indicating that the majority of BrdU-positive cells in the SGZ of these mice were *bona fide* NPCs.Figure 4miR-135a Mediates Running-Induced Proliferation in the Hippocampal SGZ *In Vivo*(A) Schematic representation of the experiment.(B) Representative micrographs showing BrdU (green), Ki67 (red), or double-positive cells (yellow arrowheads) in the hippocampal SGZ of 6- to 8-week-old C57BL/6 mice, injected with scrambled, sponge miR-135a, or sh-miR-135a virus under standard or running conditions for 10 days and subjected to three injections of BrdU 24 h before sacrifice. White arrowheads, BrdU^+^ Ki67^−^ cells; yellow arrowheads, BrdU^+^ Ki67^+^ cells.(C) Number of BrdU-positive cells per DG volume (μm^3^).(D) Percentage of BrdU^+^Ki67^−^ over total BrdU^+^ cells as a measure of cell-cycle exit.Data are expressed as means ± SEM, n = 6 mice per group. One-way ANOVA Bonferroni as *post hoc*. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. Scale bars, 50 μm.Figure 5Transient miR-135a Inhibition Stimulates Hippocampal Neurogenesis *In Vivo*(A) Schematic representation of the experiment.(B) Relative expression levels of mature miR-135a in hippocampal DG of mice injected with control scrambled or anti-miR-135a 48 h after the injection.(C and D) (C) Representative micrographs showing BrdU (black or red) cells 6 days after injection of control (scrambled) or anti-miR-135a and (D) the number of BrdU^+^ NPCs per volume (μm^3^) in the hippocampal SGZ of 6-week-old C57BL/6 mice.(E and F) Percentage of BrdU^+^DCX^+^ (E), BrdU^+^NeuN^+^ (F) over total BrdU^+^ cells in the hippocampal SGZ of 6-week-old C57BL/6 mice 3 weeks after the injection with scrambled or anti-miR-135a antagomiRs.(G and H) Representative micrographs showing staining for BrdU (red), DCX (G, green) or NeuN (H, green); and nuclear DNA with DAPI (blue); arrowheads indicate double-positive cells. H, hilus, GCL, granular cell layer; SGZ, subgranular zone.Data are expressed as means ± SEM, n = 7 mice per group. One-way ANOVA Bonferroni as *post hoc*. ^∗^p \< 0.05, ^∗∗∗∗^p \< 0.0001. Scale bars, 50 μm and 25 μm (G, high magnification).

Next, we assessed the effect of miR-135a manipulation on NPC proliferation *in vivo*. We injected viruses expressing sh-miR-135, sponge, or scrambled controls into the DG of 8-week-old C57BL/6 mice and placed them in standard cages or in cages equipped with a running wheel for 10 days, followed by BrdU administration ([Figure 4](#fig4){ref-type="fig"}A). In resting mice, miR-135a inhibition led to a significant increase in the number of BrdU-positive cells in the SGZ compared with controls ([Figures 4](#fig4){ref-type="fig"}B and 4C; p \< 0.01). In contrast, no significant differences in the number of BrdU-positive cells upon overexpression of miR-135a were observed ([Figures 4](#fig4){ref-type="fig"}B and 4C). The latter result could be explained by saturation of the system due to the high expression levels of the endogenous miR-135a in NPCs ([Figure 1](#fig1){ref-type="fig"}). Importantly, we found that overexpression of miR-135a prevented running-induced NPC proliferation in the SGZ ([Figures 4](#fig4){ref-type="fig"}B and 4C; p \< 0.05). To corroborate these results, we analyzed the proportion of cells exiting the cell cycle upon miR-135a manipulation in resting and running mice by quantifying BrdU-positive cells that were negative for Ki67 in the SGZ ([Figures 4](#fig4){ref-type="fig"}B--4D). Consistent with the antiproliferative function of miR-135a, we found a significant decrease in cell-cycle exit upon injection with the miR-135a sponge in the DG of mice housed under standard conditions ([Figure 4](#fig4){ref-type="fig"}D; p \< 0.05). In contrast, overexpression of miR-135a significantly increased cell-cycle exit in running mice ([Figure 4](#fig4){ref-type="fig"}D; p \< 0.01). These results indicate an antiproliferative function of miR-135a in NPCs and that its downregulation is necessary for the running-induced proliferation in the SGZ of adult mice.

Transient miR-135a Inhibition Stimulates Hippocampal Neurogenesis, but Not Astrogliogenesis *In Vivo* {#sec2.3}
-----------------------------------------------------------------------------------------------------

Next, we asked whether an increased proportion of proliferating NPCs, upon miR-135a inhibition, would also increase neurogenesis ([Figure 5](#fig5){ref-type="fig"}). Since constitutive inhibition of miR-135a prevents neuronal differentiation of NPCs ([@bib51]), we used synthetic "antagomiRs" to transiently inhibit miR-135a (anti-miR-135a) or scrambled control inhibitors in DG of resting mice and followed the fate of NPCs with BrdU ([Figure 5](#fig5){ref-type="fig"}A). As expected, injection of anti-miR-135a dramatically reduced endogenous miR-135a levels compared with control mice ([Figure 5](#fig5){ref-type="fig"}B; p \< 0.0001) and increased NPC proliferation, as indicated by a higher number of BrdU^+^ cells in SGZ of mice ([Figures 5](#fig5){ref-type="fig"}C and 5D; p \< 0.0001). Next, to evaluate the fate of NPCs, we quantified the proportion of cells co-expressing BrdU and the immature neuronal marker doublecortin (DCX) or the postmitotic neuronal marker NeuN in the DG 3 weeks after antagomiRs injection. Interestingly, we found that inhibition of miR-135a increased the proportions of BrdU^+^DCX^+^ ([Figures 5](#fig5){ref-type="fig"}E and 5G; p \< 0.0001) and BrdU^+^NeuN^+^ neurons compared with control mice ([Figures 5](#fig5){ref-type="fig"}F and 5H; p \< 0.05). This result indicated that increased NPC proliferation, upon transient inhibition of miR-135a, leads to enhanced neurogenesis, thus phenocopying running ([@bib64]). In contrast, miR-135a inhibition did not alter the proportion of BrdU^+^ cells expressing astrocyte markers such as GFAP ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B), glutamate transporter GLT-1 (i.e., solute carrier family 1 member 2 \[SLC1A2\]) ([Figures S3](#mmc1){ref-type="supplementary-material"}C and S3D), or glutamate aspartate transporter (GLAST) (i.e., solute carrier family 1 glial high-affinity glutamate transporter member 3 \[SLC1A3\]) ([Figures S3](#mmc1){ref-type="supplementary-material"}E and S3F). The latter result is consistent with our previous finding that adult hippocampal NPCs can undergo astrogliogenesis in absence of miRNAs ([@bib51]).

Inhibition of miR-135a Re-activates Proliferation in the Hippocampal SGZ of Aged Mice and Stimulates Cell-Cycle Re-entry of Quiescent NPCs {#sec2.4}
------------------------------------------------------------------------------------------------------------------------------------------

The age-associated reduction in adult neurogenesis has been attributed to exhaustion of the NPC pools and/or to increased NPC quiescence ([@bib21], [@bib32], [@bib41], [@bib54]). Environmental stimuli have been shown to counteract the age-associated loss of adult neurogenesis in rodents, suggesting that cell-cycle arrest of aged NPCs is reversible, at least to some extent. To verify whether miR-135a inhibition could restore NPC proliferation in the SGZ of aged mice, we injected a sponge for miR-135a in the DG of 8-week-old (young) or 90-week-old (aged) C57BL/6 mice housed under standard conditions, followed by BrdU administration (as in [Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}). Remarkably, inhibition of miR-135a significantly increased the number of BrdU-positive cells in the SGZ of both aged and young mice compared with control mice ([Figure 6](#fig6){ref-type="fig"}A). This result indicates that inhibition of miR-135a is sufficient to restore NPC proliferation in the hippocampal SGZ of aged mice, opening the possibility that it might occur through cell-cycle re-entry of quiescent NPC pools. To ascertain this possibility, we overexpressed or inhibited miR-135a in cultured NPCs ([Figures 6](#fig6){ref-type="fig"}B--6E). To simulate "aged" adult neurogenesis, we first cultured NPCs in quiescence medium for 72 h, followed by 48 h in fresh proliferative medium ([Figure 6](#fig6){ref-type="fig"}B) and measured their capacity to re-enter into proliferative state ([Figures 6](#fig6){ref-type="fig"}C--6E) by quantifying BrdU (2 h pulse, [Figures 6](#fig6){ref-type="fig"}C and 6D) or Ki67 ([Figures 6](#fig6){ref-type="fig"}C--6E). Overexpression of miR-135a impaired NPC proliferation re-entry, as shown by the lower percentage of BrdU and Ki67 positive NPCs ([Figures 6](#fig6){ref-type="fig"}C--6E) compared with control conditions ([Figures 6](#fig6){ref-type="fig"}C--6E; p \< 0.001, normalized to the short-hairpin control). Interestingly, inhibition of miR-135a stimulated re-entry of NPCs into a proliferative state, as shown by a higher percentage of BrdU and Ki67 positive NPCs compared with the scrambled control ([Figures 6](#fig6){ref-type="fig"}C--6E; p \< 0.05, normalized to the scrambled sponge). Cell-cycle analysis using propidium iodide and fluorescence-activated cell sorting (FACS) revealed that inhibition of miR-135a significantly increased the proportion of cells in the S phase (10.24% versus 20.63%, p \< 0.05) and G2/M phase (9.63% versus 12.61%; [Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B) at the expense of the G1/G0 phase (80.12% versus 66.55%; [Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B; p \< 0.01) compared with scrambled control NPCs. Moreover, inhibition of miR-135a in NPCs led to increased mRNA expression of the proliferative markers *Ki67*, *Mcm2*, and *cyclins A* and *cyclin E* ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Together, these results indicate that inhibition of miR-135a is sufficient to reactivate NPC proliferation in the SGZ of aged mice, suggesting this might occur by stimulating quiescent NPC re-entry into the proliferative state.Figure 6Inhibition of miR-135a Re-activates Proliferation in the Hippocampal SGZ of Aged Mice and Stimulates Cell-Cycle Re-entry of Quiescent NPCs(A) Number of BrdU^+^ NPCs per DG volume (μm^3^) in the hippocampal SGZ of 8-week-old (young) and 90-week-old (aged) C57BL/6 mice, injected with lentiviral sponge for miR-135a (loss of function), housed for 10 days under standard conditions, and subjected to BrdU administration (three injections every 2 h) 24 h before sacrifice.(B) Schematic representation of the *in vitro* experiment. Primary hippocampal NPCs were allowed to re-enter the cell cycle after 72 h in quiescence medium and fixed 2 h after BrdU administration.(C) Representative micrographs showing BrdU (green) and Ki67 (red) double-positive cells (yellow, arrowheads) of hippocampal NPCs infected with control sh-scrambled RNA, sh-miR-135a (gain of function), control sponge, or sponge miR-135a lentiviruses.(D) Percentage of BrdU^+^ cells relative to total cells (DAPI) normalized to controls.(E) Percentage of Ki67-positive cells relative to total cells (DAPI) normalized to controls.Data are expressed as means ± SEM, n = 3 independent experiments containing three replicates. One-way ANOVA Bonferroni as *post hoc*. ^∗^p \< 0.05, ^∗∗∗^p \< 0.001. Scale bars, 50 μm.

Phosphatidylinositol Signaling Proteins Are Modulated by miR-135a in NPCs {#sec2.5}
-------------------------------------------------------------------------

To dissect the underlying mechanism of miR-135a in adult hippocampal NPCs, we manipulated its levels *in vitro* and performed shotgun label-free proteomic analysis. Overexpression of miR-135a upregulated 431 proteins (threshold \>1.5-fold; [Table S2](#mmc3){ref-type="supplementary-material"}) and downregulated 101 proteins (threshold \<0.5-fold; [Figure 7](#fig7){ref-type="fig"}A and [Table S2](#mmc3){ref-type="supplementary-material"}); while miR-135a inhibition upregulated 326 proteins (\>1.5-fold; [Figure 7](#fig7){ref-type="fig"}A and [Table S3](#mmc4){ref-type="supplementary-material"}) and downregulated 109 (\<0.5-fold; [Table S3](#mmc4){ref-type="supplementary-material"}). Gene Ontology (GO) analysis with DAVID software ([@bib29]) indicated that the biological functions affected by miR-135a in NPCs were protein transport (GO: 001503; p value sh-miR-135a = 5.59 × 10^−6^; p value miR-135 sponge = 3.29 × 10^−4^); vesicle-mediated transport (GO: 0016192; p value sh-miR-135 = 5.34 × 10^−5^; p value miR-135 sponge = 2.10 × 10^−3^); transport (GO: 0006810; p value sh-miR-135 = 9.65 × 10^−3^; p value miR-135 sponge = 5.10 × 10^−3^), and nervous system development (GO: 0007399; p value sh-miR-135 = 9.79 × 10^−3^; p value miR-135 sponge = 2.81 × 10^−2^) ([Tables S2](#mmc3){ref-type="supplementary-material"} and [S3](#mmc4){ref-type="supplementary-material"}).Figure 7Phosphatidylinositol Signaling Proteins Are Modulated by miR-135a in NPCs(A and B) Venn diagram indicating the number of downregulated proteins (purple, \<0.5-fold) upon overexpression of miR-135a (sh-miR-135a), or upregulated proteins (yellow, \>1.5-fold) upon inhibition of miR-135a (Sponge-miR-135a), and the 17 differently expressed proteins (table in B) found in both datasets, in cultured primary hippocampal NPCs.(C) *In silico* GO analysis and KEGG pathway analysis.(D) Alignment of mouse and human miR-135a-5p and miR-135b-5p.(E) Predicted targets of miR135 according to MiRWalk. Position and length of predicted target sites of miR-135a-5p and miR-135b-5p are shown for each transcript (Ensembl ID).

miRNAs are mostly post-transcriptional repressors. Hence, to identify potential miR-135a targets, we focused on the downregulated proteins upon miR-135a overexpression and compared them with those upregulated upon miR-135a inhibition in NPCs. Seventeen proteins were consistently modulated by miR-135a levels in both datasets ([Figures 7](#fig7){ref-type="fig"}A and 7B). These proteins are involved in an intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO: 0070059; p = 0.0021, [Figure 7](#fig7){ref-type="fig"}C) and a phosphatidylinositol signaling system (mmu04070, p value 0.0249; [Figure 7](#fig7){ref-type="fig"}C). The proteins predicted to be involved in these processes were inositol 1,4,5-trisphosphate (IP3) receptor 1 (ITPR1) and BR serine threonine kinase (BRSK2), ITPR1 and inositol polyphosphate-4-phosphatase, type I (INPP4A), respectively ([Figure 7](#fig7){ref-type="fig"}C). Interestingly, the human INPP4A transcript is a validated target of miR-135a-5p (DIANA-Tarbase v8.0; [@bib33]) in the brain cortex ([@bib6]) and encodes for an enzyme involved in phosphatidylinositol metabolism. Remarkably, 11 of the 17 hits (64%) are predicted targets of miR-135 (miR-Walk 3.0; [@bib19]; both miR-135a-5p and miR-135b-5p, collectively defined as miR-135, were considered in the analysis as they share identical seed regions that are conserved in mouse and human) ([Figures 7](#fig7){ref-type="fig"}D and 7E), suggesting these proteins could be directly modulated by miR-135. As a control, we repeated the same analysis for the proteins upregulated (\>1.5-fold; [Table S2](#mmc3){ref-type="supplementary-material"}) upon miR-135a overexpression and downregulated upon miR-135a inhibition (\<0.5-fold; [Table S3](#mmc4){ref-type="supplementary-material"}). However, only 4 (17%) of the 23 proteins consistently modulated by miR-135a in both datasets were predicted targets of either human or mouse miR-135 (not shown), suggesting these proteins are likely indirectly modulated by miR-135.

Discussion {#sec3}
==========

In this study, we identify miR-135a as the first noncoding RNA essential modulator of the brain response to physical exercise. We report that overexpression of miR-135a in the DG prevents running-induced NPC proliferation. On the other hand, miR-135a inhibition stimulates NPC proliferation leading to increased neurogenesis, but not astrogliogenesis, in DG of resting mice. Remarkably, miR-135a inhibition re-activates NPC proliferation in DG of aged mice, likely by stimulating quiescent NPC pools to re-enter the cell cycle.

Several studies reported altered hippocampal miRNA expression in response to physical exercise ([@bib3], [@bib13], [@bib27], [@bib49]) or pathological conditions ([@bib22]). However, to our knowledge, this is the first study reporting a functional role of an miRNA underlying the exercise-mediated increase in adult neurogenesis. Functions of the two members of the miR-135 family are poorly described in the mammalian CNS. In postmitotic neurons, miR-135 regulates axon growth/regeneration and mediates long-term depression ([@bib28], [@bib62]). miR-135a expression is high in the amygdala of stressed mice ([@bib43]), and in the mouse raphe nucleus (functionally connected to the hippocampus) it is a key regulator of serotoninergic networks and antidepressants action ([@bib31]). However, since miR-135 association with depression- and anxiety-related phenotypes in patients is very variable ([@bib70]), its role in the pathological mechanism of these diseases remains unclear. In the adult mouse hippocampus, miR-135 is rapidly upregulated after prolonged kainic acid-induced seizures ([@bib53]). Moreover, we recently found that miR-135a is one of the 11 miRNAs required and sufficient to sustain the neurogenic lineage fate of NPCs ([@bib51]). Hence, miR-135 is required to regulate multiple aspects of adult hippocampal neurogenesis, suggesting that further studies on miR-135 in the brain response to physiological and pathological conditions are warranted.

Physical exercise is a potent trigger of adult hippocampal neurogenesis in both young and aged mice, but cellular and molecular mechanisms underlying this phenomenon remain controversial. Cellular mechanisms include recruitment of quiescent neural stem cells, acceleration of the cell cycle of NPCs, increased number of cell divisions, and reduction of cell death ([@bib47]). At the molecular level, physical exercise has been shown to increase levels of growth factors BDNF, IGF, FGF-2, and VEGF, leading to the activation of MAPK/ERK and PI3K-Akt signaling pathways ([@bib14]). We report that INPP4A, a key enzyme for phosphatidylinositol metabolism and known target of miR-135 in the cortex ([@bib6]), is one of the top proteins modulated by miR-135 in NPCs. ITPR1, another differentially expressed protein identified in our analysis, is also a key player in IP3 signaling. Hence, phosphatidylinositol signaling could represent a prominent constraint to NPC proliferative potential. This hypothesis is consistent with previous studies indicating that the PI3K-Akt signaling pathway is activated by exercise in rodents ([@bib8], [@bib11]). However, while these studies concluded that the PI3K-Akt pathway primarily mediates the effect of exercise on the survival of newly generated DG neurons and the associated increase in synaptic plasticity, our results suggest that miR-135/phosphatidylinositol signaling could mediate exercise-induced proliferation of NPCs. Together, this evidence opens the possibility that the miR-135-IP3-axis might represent a novel target of therapeutic intervention to stimulate adult neurogenesis.

One unanswered question arising from our study is how running decreases miR-135 levels in adult NPCs. miR-135 is a tumor suppressor ([@bib12], [@bib68]), which is downregulated in several cancers ([@bib26], [@bib44], [@bib50], [@bib67], [@bib69]). A Wnt/miR-135a auto-regulatory loop has been identified in brain development, which could modulate differentiation of forebrain ([@bib10]) and dopaminergic ([@bib1], [@bib15]) neurons. Moreover, Wnt/TGFβ/BMP pathways are known to influence long-term maintenance of NPC pools in the adult hippocampus, age-associated cognitive decline, and brain dysfunctions ([@bib30], [@bib61]). This evidence provides possible mechanisms to explain the rescue of proliferation in the hippocampal stem cell niche of aged mice upon miR-135 downregulation.

In summary, we propose that the therapeutic exploitation of miR-135 might offer intriguing perspectives to delay or prevent pathological brain aging.

Experimental Procedures {#sec4}
=======================

Animal Model {#sec4.1}
------------

Mice (C57BL/6J, Jackson Lab no. 000664; Td-Tomato^flox/wt^ knockin reporter mice, Jackson Lab no. 007908; [@bib42]; Nestin-CFPnuc, [@bib20]) were housed under standard laboratory conditions at Istituto Italiano di Tecnologia (IIT), the Center for Regenerative Therapies Dresden (CRTD), or the Medizinische-Theoretisches Zentrum (MTZ) Dresden. Experiments were approved by the Italian and German authorities (permit nos. 056/2013, 214/2015-PR, and 24-9168.11-1/2013-15) and conducted in accordance with the Guide for the Care and Use of Laboratory Animals of the European Community Directives. Mice were maintained under a 12 h light/dark cycle with food and water *ad libitum*.

NPC Culture {#sec4.2}
-----------

Hippocampal NPCs were prepared as previously published ([@bib2]) from ten 6-week-old C57BL/6J mice and cultured as previously described ([@bib51]). For quiescence, 1.2 × 10^4^ cells/cm^2^ were plated into normal proliferation medium; after 16 h, quiescence medium (50 ng/mL BMP4 \[R&D Systems\] and 20 ng/mL bFGF; [@bib45]) was added.

Running {#sec4.3}
-------

Nine-week-old Nestin-CFPnuc mice or WT C57BL/6J were double housed under standard conditions or in cages equipped with a running wheel (TSE System, animal facility of CRTD; or ENV-044 \[Med Associates\], Animal facility of IIT) for 10 days before sacrifice. Twenty-four hours before sacrifice, mice received one administration of 50 mg/kg BrdU (B9285, Sigma).

miRNA Manipulation {#sec4.4}
------------------

Mimics and antagomiRs used are listed in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. Scrambled miRNA mimics (50 nM; QIAGEN) or miRNA antagomiRs (150 nM; QIAGEN) were nucleofected (Amaxa) in proliferating or quiescent NPC cultures. Then, 48 h after nucleofection, 10 μM BrdU was added to the medium for 2 h, followed by fixation (4% PFA) or RNA/protein extraction. Virus and synthetic oligos were stereotaxically injected in the hippocampus (coordinates: −2.0 A/P, ±1.6 M/L, and −1.9 to −2.1 D/V relative to bregma \[mm\]) as previously described ([@bib51]). Codes for viruses and oligos are listed in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. After virus injection, mice received three BrdU intraperitoneal injections per day (100 mg/kg, every 2 h) and sacrificed 24 h later. After injection of oligos, mice received two BrdU intraperitoneal injections per day (50 mg/kg) for 5 days and sacrificed 2 h (6 days post injection of oligos) or 2 weeks after the last BrdU injection (21 days post injection of oligos).

Immunofluorescence and Cell Quantification {#sec4.5}
------------------------------------------

Immunofluorescence staining on brain slices (40 μm) was performed in one of every six sections of the hippocampus. A list of primary antibodies and the detailed protocol is provided in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. Confocal stack images of brain slices were obtained with the Confocal A1 Nikon Inverted SFC with 40× objective and the Zeiss Spinning Disc with a 20× objective. Cell quantification and analysis were performed using NIS-Elements software (Nikon) and ZenBlue (Zeiss). Immunofluorescence on cell cultures was performed as previously described ([@bib51]). Images were obtained using a Nikon Eclipse microscope at 20× or 40× magnification, and quantification was performed using a cell-counter plugin in Fiji (Fiji is just ImageJ; [@bib52]).

FACS and RNA Analysis {#sec4.6}
---------------------

For RNA extraction and cDNA preparation, 6--10 *Nestin*-CFPnuc mice per condition were euthanized at the indicated times. Cells were dissociated with the Neural Tissue Dissociation Kit P (Miltenyi), FACS sorted, and immediately processed for RNA extraction ([@bib66]). Total RNA was extracted with QIAzol (QIAGEN), RNA was purified with an RNeasy Kit, or miRNeasy Kit (QIAGEN) following the manufacturer\'s instructions. Quantification of RNA was performed as in [@bib51].

*In Situ* Hybridization {#sec4.7}
-----------------------

*In situ* hybridization was performed as previously published ([@bib17]) with minor modifications. Brain slices (18--20 μm) were permeabilized and post-fixed in 4% PFA. Slides were blocked with 0.25% acetic anhydride (Sigma), and a pre-hybridization solution was added, followed by incubation with a hybridization solution containing 160 nM (miR-135, -190, -203) or 100 nM (miR-9) of the DIG-labeled LNA probe (Exiqon) overnight. The anti-DIG antibody (Roche; 1:2000) was incubated overnight at 4°C. For development of the color reactions, two different alkaline phosphatase substrates were used: NBT/BCIP (Roche) or Fast Red TR/Naphthol AS-MX solution (Sigma), following the manufacturers\' instructions. Sections were mounted and imaged using conventional bright-field microscopy or a confocal microscope with the Cy-3 filter.

Proteomics {#sec4.8}
----------

NPCs (three independent experiments) were lysed with RIPA buffer, and 50 μg of proteins was collected from all the samples and processed as previously described ([@bib7]). Protein pools were processed for liquid chromatography-tandem mass spectrometry analysis.

Statistical Analysis {#sec4.9}
--------------------

Data are presented as means ± SEM and were analyzed using Prism 6 (GraphPad). Statistical details of the experiments can be found in the Results and figure legends. Statistical significance was assessed with a two-tailed unpaired t test for two experimental groups. For experiments with three or more groups, one-way ANOVA with Bonferroni\'s multiple comparison test *post hoc* was used. Mean differences were considered to be statistically significant when p \< 0.05.
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